United States · FDA National Drug Code directory
OSELTAMIVIR PHOSPHATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1712_1e8d55a0-7d87-4135-886c-d0e6591d9917
- Product NDC
- 70771-1712
- Form
- CAPSULE
- Composition / generic term
- oseltamivir phosphate
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170224
- Source listing expiry
- 20261231
Source-listed ingredients
- OSELTAMIVIR PHOSPHATE — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (70771-1712-2) / 10 CAPSULE in 1 BLISTER PACK · 70771-1712-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →